Purespring Therapeutics: Pioneering Gene Therapy For Kidney Disorders
Recently Appointed CEO Richard Francis Outlines Development Path
Interview: recently appointed CEO Richard Francis will apply his background in big pharma and biotech to building the UK start-up Purespring Therapeutics with a focus on using gene therapy technology to target renal diseases.
